z-logo
open-access-imgOpen Access
Azithromycin and the Risk of Cardiovascular Death
Author(s) -
Wayne A. Ray,
Katherine T. Murray,
Kathi Hall,
Patrick G. Arbogast,
Christoph Stein
Publication year - 2012
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1003833
Subject(s) - medicine , azithromycin , hazard ratio , relative risk , cohort , confidence interval , antibiotics , microbiology and biotechnology , biology
Although several macrolide antibiotics are proarrhythmic and associated with an increased risk of sudden cardiac death, azithromycin is thought to have minimal cardiotoxicity. However, published reports of arrhythmias suggest that azithromycin may increase the risk of cardiovascular death.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom